concussion
Tesis Biosciences to Develop miRNA Biomarkers for mTBI Diagnosis
On the heels of its Genome Explorations acquisition, the company wants to create a biomarker panel to differentiate mild traumatic brain injury from PTSD.
The firm said it believes that the results of a recent study are representative of the broader utility of the test and its potential for broad application to diagnose concussions.
Quadrant Biosciences Wins $2.3M NIH Grant to Develop Saliva Test for Concussion
The company and its collaborators previously published a study linking saliva concentrations of multiple microRNAs with concussion duration and symptoms in children.
Quadrant Biosciences Licenses SUNY, Penn State Epigenetic Biomarkers for Neuro Diseases
The company hopes to develop saliva-based RNA assays for concussion, Parkinson's disease and autism using biomarkers discovered by its two academic partners.
BU, Seqster Partner on Traumatic Brain Injury Study
Newly launched aggregator Seqster will help Boston University researchers collect data from EHRs, wearables, and gene tests to identify concussion biomarkers.